pedal arterial catheter was advanced iust beyond the femoral Insulin has a specific effect on increasing fetal glucose uptake and utilization.
+ 7 ml. min-I kg-' vs. 109 + 8ml-min-I kg-') and urea (24.5 + 2.2 mlemin-I. kg-' vs. 25.0 + 2.1 ml-min-'.kg1). Fetal plasma glucose concentration fell significantly (0.22 + 0.01 mg.ml-I to 0. 16 + 0.01 mg-ml-I) during insulin infusion. The insulin effect on fetal glucose uptake occurred over a range of maternal glucose concentrations (0.32 + 0.78 mg-ml-I), which were not altered by the infusion of insulin in the fetal compartment.
Insulin has a specific effect on increasing fetal glucose uptake and utilization.
Speculation
The effect of insulin on increasing transplacental fetal glucose uptake is consistent with a growth-promoting role for insulin in the fetus. This action of insulin might be due to a direct effect of insulin on the mechanisms of placental glucose transport, to an alteration of placental glucose catabolism, or simply to the effect of insulin on the transplacental gradient of glucose.
The injection of large doses of insulin into the fetal circulation has previously been shown to cause only minimal decreases in the concentration of fetal plasma glucose in both the rhesus monkey (5) and sheep (7). This observation has been considered as evidence that insulin may not control the rate of fetal glucose utilization. However, even a substantial increase in fetal glucose utilization might not have any dramatic effect on fetal glucose concentration if insulin administration simultaneously led to an increase transfer of glucose from placenta to fetus. Studies on the effect of insulin on the glucose uptake or metabolism of in vitro placenta have produced conflicting results (2, 18, 19). Thus, observations on the effect of insulin on glucose uptake into the umbilical circulation under stable in vivo conditions are of crucial importance in establishing whether or not insulin controls the rate of fetal glucose utilization. We now report evidence that the infusion bf insulin into the fetal circulation leads to an increase in glucose uptake and utilization by the fetus.
MATERIALS AND METHODS
irtery to sample the arterial blood "supply~ng the umbilical artery. The fetal pedal venous catheter was advanced to the femoral vein and was used for the constant antipyrine, urea, and insulin infusions. The animals were allowed to recover from surgery for a minimum of 4 days prior to any study period. Each animal was studied on two occasions within 24 hr. The sequence of control and insulin-infusion periods was varied among animals.
During the control period baseline measurements of umbilical blood flow and antipyrine and urea placental clearances were made using the antipyrine and the urea steady state diffusion technique (13) . Four simultaneous samples of umbilical venous (v) and arterial (a) blood were obtained at 15-to 20-min intervals and a venoarterial concentration difference for glucose ' calculated using whole blood glucose concentrations. Applying the Fick principle, glucose uptake and utilization (QG113 by the fetus was calculated as Q=,,, (mglmin) = umbilical whole blood (v-a) glucose (mglml) x umbilica1 blood flow (ml/min)
A smiliar calculation was made to compute the oxygen consump tion of the fetus. During the insulin study period, the same measurements were repeated while the fetus was receiving a constant intravenous infusion of crystalline bovine zinc insulin (Eli Lilly and Co.). Based on an estimate of fetal weight at the time of surgery, the fetus was given a -0.1 p/kg priming dose followed by a constant infusion at a rate of -0.24 p/kg/hr over a 2.5-3.5-hr study period. This dose was calculated to approximate a plasma insulin concentration of 1 mU/ml (7). The sampling period was from 1.5-3.5 hr after beginning the insulin infusion.
Antipyrine was measured on whole blood using a Technicon AutoAnalyzer (13) . Urea was measured on plasma using the Beckman BUN analyzer urease method (16) . Glucose was. measured on whole blood and plasma by a glucose oxidase method (16, 17) . Statistical analyses were by the paired Student's t-test (15).
RESULTS
Comparison of insulin and control period measurements are shown in Table 1 . Insulin administration had no significant effect on umbilical blood flow (0.15 < P < 0.2), antipyrine placental clearance (0.2 < P < 0.3), urea placental clearance (0.15 < P < 0.02), and fetal oxygen consumption (0.15 4 P < 0.02). Insulin infusion led to a significant fall in fetal arterial plasma glucose concentration ( P < 0.001), but had no effect on the maternal arterial elucose concentration (0.2 < P < 0.3).
Mean glucose uptakg (utilization) by the'fetus increased during insulin infusion ( P < 0.001). in the face of sienificant 0 -, .
0
Ten Western-bred ewes with gestations of 95 to 145 days had fetal hypoglycemia. Glucose uptake (utilization) increased under polyvinyl catheters placed in the fetal umbilical vein, a fetal the influence of insulin in each study animal. Previous studies pedal artery, a fetal pedal vein, and in the maternal femoral have demonstrated a positive correlation of fetal glucose uptake artery while under pentobarbital sedation (5 mg/kg) and Ponto-with the maternal arterial glucose concentration (1 1). Figure 1 caine spinal anesthesia (6 mg in hyperbaric glucose). The fetal confirms the above finding and demonstrates that fetal glucose Because of the anabolic nature of its actions, insulin might .6
.7
.8
and in vivo (7, 14) evidence.
possible that the-growth-promoting effect of insulin is mediated uptake is a function of both the maternal glucose concentration in part by its effect on increasing fetal glucose uptake and and the level of insulin in the fetus. utilization demonstrated in this study.
DISCUSSION
The animals in this report were studied at a wide range of gestational ages (95-145 days). There were no differences in insulin effect detected over this range of age, although the number of animals studied before 100 days is inadequate for making any definitive statement about insulin effects at different stages of fetal maturity.
The dosage of insulin administered to the fetuses in this study would be anticipated to cause an increase in fetal plasma insulin concentration 20-50 times the usual physiologic concentrations. This large dose was selected because previous studies using similar doses were interpreted as showing little effect of insulin in controlling fetal glucose utilization. It cannot be stated whether more modest insulin doses, and thus more physiologic insulin concentrations, would lead to similar findings.
The mechanism by which insulin infusion leads to increased glucose umbilical uptake needs further investigation. A significant increase in the maternal to fetal plasma glucose concentration difference occurred in the present study (Table 1 ) and was secondary to a fall in the fetal arterial glucose concentration. Previous studies have demonstrated the relationship between fetal glucose uptake and the maternal to fetal glucose concentration difference (1 1). Thus, insulin might increase fetal glucose uptake simply by decreasing the fetal arterial glucose concentration and enlarging the glucose cocentration gradient across the placenta. However, as shown in 
